Siemens’ medical technology division Siemens Healthineers has started works on a new $300m manufacturing and research and development (R&D) facility for laboratory diagnostics at Walpole, Massachusetts, in the US.
Expected to create approximately 700 new jobs over the coming ten years, the new facility is intended to enhance customer experience by strengthening healthcare operations.
The firm is currently reported to provide more than ten billion laboratory diagnostic tests every year and plans to further bolster its footprint.
Siemens Healthcare supervisory board chairman Michael Sen said: “Our mission is to extend this reach even further and Walpole will play a major role in this effort. That’s why we’re investing $300m here – one of the largest single capital investments of Siemens Healthcare in the US ever."
The company invests more than $1bn annually for R&D in the US and the latest investment is anticipated to expand its capabilities to provide simple solutions for lab professionals, enabling them to spend less time on operations and contribute to better outcomes.
Siemens Corporation chair and CEO Lisa Davis said: “By investing in advanced manufacturing right here in the US, Siemens creates value for customers and communities, produces high-wage jobs, increases exports and creates more orders for local businesses of all sizes.”
Siemens Healthineers develops products and services across diagnostic, therapeutic imaging, laboratory diagnostics and molecular medicine segments.
The firm currently operates more than 60 manufacturing sites in the US.
Image: Rendering of Siemens’ future manufacturing and R&D facility in Walpole, US. Photo: courtesy of Siemens Healthineers.
